MERS-CoV: Understanding the Latest Human Coronavirus Threat

MERS-CoV: Understanding the Latest Human Coronavirus Threat

Aasiyah Chafekar, Burtram C. Fielding

Human coronaviruses cause both upper and lower respiratory tract infections in humans. In 2012, a sixth human coronavirus (hCoV) was isolated from a patient presenting with severe respiratory illness. The 60-year-old man died as a result of renal and respiratory failure after admission to a hospital in Jeddah, Saudi Arabia. The aetiological agent was eventually identified as a coronavirus and designated Middle East respiratory syndrome coronavirus (MERS-CoV). MERS-CoV has now been reported in more than 27 countries across the Middle East, Europe, North Africa and Asia. As of July 2017, 2040 MERS-CoV laboratory confirmed cases, resulting in 712 deaths, were reported globally, with a majority of these cases from the Arabian Peninsula. This review summarises the current understanding of MERS-CoV, with special reference to the (i) genome structure; (ii) clinical features; (iii) diagnosis of infection; and (iv) treatment and vaccine development.

2018

human coronavirus, MERS-CoV, clinical features, Upper respiratory tract infections, lower respiratory tract infections, Respiratory viruses

DOI: 10.3390/v10020093

Viruses

MDPI AG

Microbiology

EN